Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System
Background: Immune checkpoint inhibitors (ICIs) improve cancer survival but can provoke new or worsening autoimmune disease. Objectives: To explore the association of ICIs with multiple sclerosis (MS) using the U.S. Food and Drug Administration’s Adverse Event Reporting System (FAERS) database, and...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2025-11-01
|
| Col·lecció: | Therapeutic Advances in Neurological Disorders |
| Accés en línia: | https://doi.org/10.1177/17562864251392211 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|